Actionable Stock Market Trading Newswire. Built for Traders, by Traders. All news is property of their respective owners.
HomeNewsfeedsAthenex HK Innovative Limited (Sha Tin, HK) Granted U.S. Patent #11,389,442 Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
Athenex HK Innovative Limited (Sha Tin, HK) Granted U.S. Patent #11,389,442 Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancer
PHASE 2 FINAL INVESTMENT DECISION ($ USD)The capital expenditure ("Capex") for Phase 2 Industrial Greentech Plant is targeted to be USD $100 million, aiming to increase the Company's total annual lithium capacity by
FAT Brands (NASDAQ:FAT) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.85) by 15.29 percent. This is a 600 percent decrease over losses of $(0.14) per share from the
Streaming markets have continued to heat up, as media and technology companies spend billions of dollars on original content and acquired content. One key feature that is setting some streaming networks apart is sports content.